New product - new possibilities: RRS HA Long Lasting

Innovative preparation

2023-05-01

The Skin Tech Pharma Group company presents an innovative dermal implant with the effect of filler and biorevitalizer, as well as the new patented CO-Delivery technology. In addition, the company uses the innovative technological approach of Unheating, which prevents the partial disintegration of the newly created cross-linked hyaluronic acid.

Evgenyia Ranneva, candidate of medical sciences, dermatocosmetologist, specialist in the field of rehabilitation and restorative medicine, doctor of philosophy (Ukraine, Spain)

1. When developing the product, what goals did you set for yourself and which patient were you targeting?
This is a completely new project activity in which, in the process of development, we managed to combine variously directed drugs with the aim of obtaining a new hybrid that meets both the patient's and the doctor's requirements. It was a revolutionary idea to create a universal drug, in the work of which the cosmetologist would have the opportunity after administration to distribute the product depending on the individual needs of each patient.

2. Tell in more detail about the advantages and uniqueness of CO-DELIVERY and Unheating technologies.
Cross-linked hyaluronic acid was added to the composition of the RRS® HA LONG LASTING preparation, in the manufacture of which a fairly new raw material extraction technology was used, and a protective buffer consisting of a set of amino acids stabilized by a phosphate buffer was used, thanks to which they do not react with each other. also introduced a completely new ingredient - osmolyte.